Find trials
Search tips

Function and Dysfunction in Leukocytes

Overview

About this study

The purpose of this study is to evaluate the effect of different treatments on human white blood cells. Determine how inhibition/activation of immune cell signaling of affects inflammation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Healthy adults 18 years and older.

Exclusion Criteria:

  • Pregnant women, subjects under 18 years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/03/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Juliana Yerneni, Ph.D.

Contact us for the latest status

Contact information:

Jenna Capelle

(507) 266-5017

Capelle.Jenna@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20582506

Mayo Clinic Footer